Cancer Updates
Cancer news from the American Cancer Society.
Filtering by:
Targeted TherapyTargeted Drug Trastuzumab Deruxtecan Slows Growth of Metastatic Breast Cancer
Published on: July 26, 2024
A study of the HER2-targeted therapy drug trastuzumab deruxtecan (Enhertu) shows it can stop metastatic breast cancer growth for longer than chemotherapy.
Targeted Drug Stops Lung Cancer Growth for Five Years in Over Half of People with Mutated Lung Cancer
Published on: June 13, 2024
A study shows that a targeted therapy drug stops the spread of lung cancer for 5 years or more. The drug, lorlatinib (Lobrena), also stops new cancer growth in the brain.
Targeted Cancer Drug Lowers Risk of Cancer Growth or Death in Lung Cancer with a Specific Mutation
Published on: June 13, 2024
A study has shown that giving patients with lung cancer a targeted therapy drug after combined chemotherapy and radiation therapy helps them live longer without the cancer growing or spreading.
FDA Approves Trodelvy (Sacituzumab govitecan-hziy) for Triple Negative Breast Cancer
Published on: April 29, 2020
The US Food and Drug Administration (FDA) approved a new type of therapy for triple-negative breast cancer that has spread to other parts of the body and hasn’t responded to other treatments.
FDA Approves Pemazyre (Pemigatinib) for Bile Duct Cancer
Published on: April 22, 2020
The US Food and Drug Administration (FDA) approved the first targeted therapy for bile duct cancer. Pemazyre (pemigatinib) is for adults whose cancer has grown after at least one previous chemotherapy treatment and whose tumors have a mutation in the FGFR2 gene.